다우존스 지수

실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

등록

DMA

DiaMedica Inc. (DMA)

Diamedica Therapeutics

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:TSXV:DMA

1 2 3 4 5 6 7 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2014/07/30	21:00	Marketwired Canada	DiaMedica to Present at InvestMNt Conference on August 6, 2014	TSXV:DMA	Diamedica Therapeutics
2014/07/26	05:30	Marketwired Canada	DiaMedica Inc. Announces Results of Annual General and Special Meeting of Shareholders	TSXV:DMA	Diamedica Therapeutics
2014/07/10	21:30	Marketwired Canada	DiaMedica Promotes Mark Robbins to Executive Vice President	TSXV:DMA	Diamedica Therapeutics
2014/07/09	06:09	Marketwired Canada	DiaMedica Announces Stock Option Grant	TSXV:DMA	Diamedica Therapeutics
2014/07/07	21:30	Marketwired Canada	DiaMedica Appoints Rich Pilnik as Chairman of the Board of Directors	TSXV:DMA	Diamedica Therapeutics
2014/06/10	20:30	Marketwired Canada	DiaMedica to Present Clinical Abstract on DM199 at the 74th Annual American Diabetes Association Conference	TSXV:DMA	Diamedica Therapeutics
2014/06/10	20:30	Marketwired	DiaMedica to Present Clinical Abstract on DM199 at the 74th Annual American Diabetes Association Conference	TSXV:DMA	Diamedica Therapeutics
2014/06/05	23:22	Marketwired Canada	DiaMedica Announces Development Update	TSXV:DMA	Diamedica Therapeutics
2014/06/05	23:22	Marketwired	DiaMedica Announces Development Update	TSXV:DMA	Diamedica Therapeutics
2014/06/03	23:56	Marketwired Canada	DiaMedica Inc. Appoints Dr. Ralph A. DeFronzo to its Scientific Advisory Board	TSXV:DMA	Diamedica Therapeutics
2014/06/03	23:56	Marketwired	DiaMedica Inc. Appoints Dr. Ralph A. DeFronzo to its Scientific Advisory Board	TSXV:DMA	Diamedica Therapeutics
2014/05/28	00:53	Marketwired Canada	DiaMedica Announces Completion of Prospectus Offering	TSXV:DMA	Diamedica Therapeutics
2014/05/21	05:22	Marketwired Canada	DiaMedica Inc. Announces Filing of Final Prospectus	TSXV:DMA	Diamedica Therapeutics
2014/05/13	07:26	Marketwired Canada	DiaMedica Inc. Finalizes Terms of Public Offering	TSXV:DMA	Diamedica Therapeutics
2014/05/08	20:05	Marketwired Canada	DiaMedica Inc. Provides Update on Public Offering	TSXV:DMA	Diamedica Therapeutics
2014/04/26	06:50	Marketwired Canada	DiaMedica Inc. Amends the Expiry Date of Warrants	TSXV:DMA	Diamedica Therapeutics
2014/04/23	05:05	Marketwired Canada	DiaMedica Inc. Announces Public Offering	TSXV:DMA	Diamedica Therapeutics
2014/04/17	22:28	Marketwired Canada	DiaMedica Inc. to Amend the Expiry Date of Warrants	TSXV:DMA	Diamedica Therapeutics
2014/04/15	22:00	Marketwired Canada	DiaMedica to Present at the 2014 GTC Diabetes Summit	TSXV:DMA	Diamedica Therapeutics
2014/04/15	22:00	Marketwired	DiaMedica to Present at the 2014 GTC Diabetes Summit	TSXV:DMA	Diamedica Therapeutics
2014/04/07	22:07	Marketwired	DiaMedica Appoints John Savage as Chief Financial Officer	TSXV:DMA	Diamedica Therapeutics
2014/04/07	22:06	Marketwired Canada	DiaMedica Appoints John Savage as Chief Financial Officer	TSXV:DMA	Diamedica Therapeutics
2014/03/26	01:14	Marketwired Canada	Granite Creek Cancels Consulting Agreement	TSXV:DMA	Diamedica Therapeutics
2014/02/19	22:30	Marketwired	DiaMedica Files 20-F Registration Statement with U.S. SEC and Provides Clinical Update	TSXV:DMA	Diamedica Therapeutics
2014/02/19	21:30	Marketwired Canada	DiaMedica Files 20-F Registration Statement with U.S. SEC and Provides Clinical Update	TSXV:DMA	Diamedica Therapeutics
2014/02/06	02:15	Marketwired	DiaMedica to Present at 16th Annual BIO CEO & Investor Conference	TSXV:DMA	Diamedica Therapeutics
2014/02/06	01:15	Marketwired Canada	DiaMedica to Present at 16th Annual BIO CEO & Investor Conference	TSXV:DMA	Diamedica Therapeutics
2014/01/23	07:10	Marketwired Canada	DiaMedica Inc. Announces Partial Exercise of Over-Allotment Option	TSXV:DMA	Diamedica Therapeutics
2014/01/09	22:30	Marketwired	DiaMedica Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of DM199 in Type 2 Diabetic Patients	TSXV:DMA	Diamedica Therapeutics
2014/01/09	21:30	Marketwired Canada	DiaMedica Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of DM199 in Type 2 Diabetic Patients	TSXV:DMA	Diamedica Therapeutics

검색 관련기사 보기:TSXV:DMA

1 2 3 4 5 6 7 다음 >>

Invesco MSCI Emerging Ma...

WSP Global (PK)

Amundi FTSE 100 UCITS ET...

Stand.chart. Re

Granite 3xs Vod

REIT Growth and Income S...

SNCF Mobilites 1.375% 20...

Accolade Partners Ix

Adams Street Partners Co...

Highlight Communications

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관